Vinorelbine and fatigue Patient Reports February 12, 2012

Vinorelbine Side Effects Report #4854418-3
Vinorelbine side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 14, 2005. Female patient, 60 years of age, weighting 231.5 lb, was diagnosed with squamous cell carcinoma of the cervix and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: anorexia, body temperature increased, fatigue, neutrophil count decreased, white blood cell count decreased. Vinorelbine dosage: unknown. During the same period patient was treated with CISPLATIN, MISCARDIS, PEPCID, SENOKOT, STOOL SOFTENERS. Patient was hospitalized. Patient recovered.

Vinorelbine Side Effects Report #4854271-8
Vinorelbine side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 13, 2005. Female patient, weighting 231.5 lb, was diagnosed with granulocytes abnormal, neutrophil count abnormal, squamous cell carcinoma and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: anorexia, body temperature increased, fatigue, neutrophil count decreased, white blood cell count decreased. Vinorelbine dosage: unknown. During the same period patient was treated with VINORELBINE TARTRATE, VINORELBINE TARTRATE, CISPLATIN, MISCARDIS, PEPCID, SENOKOT, STOOL SOFTENERS. Patient was hospitalized. Patient recovered.

Vinorelbine Side Effects Report #5009274-X
Vinorelbine side effect was reported by a Health Professional from UNITED STATES on May 08, 2006. Female patient was diagnosed with cervix carcinoma recurrent and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: fatigue, neutropenia. Vinorelbine dosage: 30 MG/M 2. Patient recovered.

Vinorelbine Side Effects Report #5009275-1
Vinorelbine side effect was reported by a Health Professional from UNITED STATES on May 08, 2006. Female patient was diagnosed with cervix carcinoma recurrent and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: fatigue, hypertension, lung disorder, neutropenia, renal disorder. Vinorelbine dosage: 30 MG/M 2. Patient recovered.


Vinorelbine Side Effects Report #5009277-5
Vinorelbine side effect was reported by a Health Professional from UNITED STATES on May 08, 2006. Female patient was diagnosed with cervix carcinoma recurrent and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: fatigue, hypertension, lung disorder, neutropenia, renal disorder. Vinorelbine dosage: 30 MG/M**2. Patient recovered.

Vinorelbine Side Effects Report #5009281-7
Vinorelbine side effect was reported by a Health Professional from UNITED STATES on May 08, 2006. Female patient was diagnosed with cervix carcinoma recurrent and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: fatigue, hypertension, lung disorder, renal disorder. Vinorelbine dosage: 30 MG/M**2. Patient recovered.

Vinorelbine Side Effects Report #6035495-3
Vinorelbine side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 12, 2009. Female patient, weighting 182.8 lb, was diagnosed with breast cancer  and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: adrenal insufficiency, anorexia, blood sodium decreased, diarrhoea, fatigue, haematocrit decreased, haemoglobin decreased, inappropriate antidiuretic hormone secretion. Vinorelbine dosage: 25MG/M2 WEEKLY IV. During the same period patient was treated with CLONAZEPAM, COMPAZINE, EFFEXOR, LORAZEPAM, ZESTORETIC, LEVAQUIN, BEVACIZUMAB, HERCEPTIN. Patient was hospitalized. Patient recovered.

Vinorelbine Side Effects Report #5628576-7
Vinorelbine side effect was reported by a Health Professional from UNITED STATES on Feb 14, 2008. Female patient, weighting 126.0 lb, was diagnosed with adenocarcinoma, metastasis, metastatic neoplasm and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: blood phosphorus increased, confusional state, fatigue, hypercalcaemia, hyponatraemia, hypophosphataemia, laboratory test abnormal, urinary incontinence . Vinorelbine dosage: 25MG/M2 D 1,8,15 Q 28 D IV. During the same period patient was treated with LAPATINIB. Patient was hospitalized. Patient recovered.

Vinorelbine Side Effects Report #5732806-0
Vinorelbine side effect was reported by a Health Professional from UNITED STATES on May 07, 2008. Female patient, weighting 126.0 lb, was diagnosed with adenocarcinoma, metastasis and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: confusional state, fatigue, hypophosphataemia, urinary incontinence . Vinorelbine dosage: 25 MG/M2 D 1, 8, 15 Q 28 D IV. During the same period patient was treated with LAPATINIB. Patient died on 02/19/2008.


Vinorelbine Side Effects Report #4863124-0
Vinorelbine side effect was reported by a Physician from UNITED STATES on Sept 16, 2005. Female patient, 73 years of age, was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: burning sensation, fatigue, hyperhidrosis, hypotension, nausea , skin discolouration, syncope. Vinorelbine dosage: 40 MILLIGRAM DAILY INTRAVENOUS (NOS). Patient recovered.

Vinorelbine Side Effects Report #4863123-9
Vinorelbine side effect was reported by a Physician from UNITED STATES on Sept 16, 2005. Female patient, 71 years of age, was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: burning sensation, fatigue, hyperhidrosis, hypotension, nausea , skin discolouration, syncope. Vinorelbine dosage: 40 MILLIGRAM DAILY INTRAVENOUS (NOS). Patient recovered.